Vitamin Shoppe, Inc (VSI) Given Consensus Recommendation of “Hold” by Analysts

Shares of Vitamin Shoppe, Inc (NYSE:VSI) have earned an average rating of “Hold” from the thirteen ratings firms that are presently covering the firm. Eleven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $30.78.

VSI has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of Vitamin Shoppe from a “sell” rating to a “buy” rating and set a $27.00 price target for the company in a report on Friday. Morgan Stanley cut shares of Vitamin Shoppe from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $32.00 to $26.00 in a report on Thursday, November 3rd. Barclays PLC reaffirmed an “equal weight” rating and issued a $29.00 price target on shares of Vitamin Shoppe in a report on Wednesday, November 2nd. Jefferies Group reaffirmed a “hold” rating and issued a $28.00 price target on shares of Vitamin Shoppe in a report on Monday, September 26th. Finally, J P Morgan Chase & Co cut shares of Vitamin Shoppe from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $33.00 to $28.00 in a report on Thursday, October 27th.

TRADEMARK VIOLATION NOTICE: “Vitamin Shoppe, Inc (VSI) Given Consensus Recommendation of “Hold” by Analysts” was published by Mideast Time and is the propert of of Mideast Time. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this piece of content can be accessed at https://www.mideasttime.com/vitamin-shoppe-inc-vsi-given-consensus-recommendation-of-hold-by-analysts/1471192.html.

In other news, CAO Dan Lamadrid sold 1,734 shares of the stock in a transaction on Tuesday, November 8th. The shares were sold at an average price of $23.20, for a total value of $40,228.80. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.29% of the stock is currently owned by insiders.

Several hedge funds have recently added to or reduced their stakes in the company. Emerald Acquisition Ltd. acquired a new stake in Vitamin Shoppe during the second quarter worth $355,000. Wells Fargo & Company MN raised its stake in Vitamin Shoppe by 6.7% in the third quarter. Wells Fargo & Company MN now owns 261,657 shares of the company’s stock valued at $7,026,000 after buying an additional 16,427 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Vitamin Shoppe by 22.4% in the second quarter. Dimensional Fund Advisors LP now owns 2,047,529 shares of the company’s stock valued at $62,593,000 after buying an additional 374,360 shares in the last quarter. Schroder Investment Management Group purchased a new stake in Vitamin Shoppe during the second quarter valued at approximately $4,891,000. Finally, Mason Street Advisors LLC purchased a new stake in Vitamin Shoppe during the second quarter valued at approximately $145,000.

Vitamin Shoppe (NYSE:VSI) opened at 23.15 on Tuesday. The company’s 50 day moving average is $24.92 and its 200-day moving average is $27.12. Vitamin Shoppe has a 1-year low of $21.90 and a 1-year high of $32.62. The stock has a market cap of $542.43 million, a PE ratio of 13.65 and a beta of 0.64.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, November 2nd. The company reported $0.50 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.50. The business earned $314.90 million during the quarter, compared to analysts’ expectations of $317.18 million. Vitamin Shoppe had a net margin of 3.34% and a return on equity of 11.52%. The business’s quarterly revenue was up .3% on a year-over-year basis. During the same quarter last year, the company posted $0.52 earnings per share. Equities research analysts forecast that Vitamin Shoppe will post $2.13 earnings per share for the current fiscal year.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

5 Day Chart for NYSE:VSI

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.